Systematic review / meta-analysis / 2015
Soy isoflavones produced a 25.2% maximal reduction in menopausal hot flashes after accounting for placebo, acting much slower than estradiol.
A model-based meta-analysis analyzed 16 studies covering about 1,710 subjects to model the time course of hot flash reduction with soy isoflavones versus placebo. The maximal reduction by soy isoflavones after eliminating the placebo effect was 25.2%, representing 57% of the maximum effect seen with estradiol (44.9%). Soy isoflavones required 13.4 weeks to reach half of their maximal effect, compared to 3.09 weeks for estradiol, and would require at least 48 weeks to achieve 80% of their maximum effect. The authors concluded that soy isoflavones exhibit slight and slow effects in reducing hot flashes compared with estradiol.
- Study type
- Model-based meta-analysis
- Who was studied
- About 1,710 menopausal subjects across 16 studies
- What was measured
- Time-effect course and maximal reduction of menopausal hot flashes
THE PAPER
Quantitative efficacy of soy isoflavones on menopausal hot flashes.
Li L, Lv Y, Xu L, Zheng Q. Br J Clin Pharmacol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.